Safe Orthopaedics SA (EPA:ALSAF)
France · Delayed Price · Currency is EUR 0.6150
+0.0150 (2.50%)
Jun 26, 2026, 12:09 PM CET
Safe Orthopaedics Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 5.04 | 5.81 | 5.86 | 4.55 | 3.66 | |
Revenue Growth (YoY) | -13.24% | -0.87% | 28.70% | 24.49% | -22.15% |
Cost of Revenue | 2.48 | 1.59 | 2.2 | 1.98 | 2.26 |
Gross Profit | 2.57 | 4.22 | 3.66 | 2.57 | 1.4 |
Selling, General & Admin | 7.8 | 7.66 | 8.87 | 9.27 | 7.52 |
Other Operating Expenses | -3.79 | -0.13 | -0.16 | 0.02 | -0.03 |
Operating Expenses | 5.01 | 10.41 | 9.62 | 10.16 | 8.07 |
Operating Income | -2.45 | -6.19 | -5.96 | -7.58 | -6.67 |
Interest Expense | -2,122 | -0.22 | -0.42 | -0.64 | -0.86 |
Interest & Investment Income | 259.64 | - | 0.21 | - | - |
Currency Exchange Gain (Loss) | - | 0.36 | -0.64 | 1.51 | -0.78 |
Other Non Operating Income (Expenses) | 0 | -263.48 | -0.15 | -0 | 0 |
EBT Excluding Unusual Items | -1,864 | -269.52 | -6.97 | -6.71 | -8.31 |
Impairment of Goodwill | - | -1.79 | - | - | - |
Asset Writedown | 0.2 | - | - | - | - |
Pretax Income | -1,864 | -271.32 | -6.97 | -6.71 | -8.31 |
Income Tax Expense | 65.21 | -65.87 | -0 | - | - |
Net Income | -1,929 | -205.44 | -6.97 | -6.71 | -8.31 |
Net Income to Common | -1,929 | -205.44 | -6.97 | -6.71 | -8.31 |
Shares Outstanding (Basic) | 2,081 | 2,081 | - | - | - |
Shares Outstanding (Diluted) | 2,081 | 2,081 | - | - | - |
EPS (Basic) | -0.93 | -0.10 | - | - | - |
EPS (Diluted) | -0.93 | -0.10 | - | - | - |
Free Cash Flow | -3.36 | 64.69 | -6.33 | -8.22 | -6.53 |
Free Cash Flow Per Share | -0.00 | 0.03 | - | - | - |
Gross Margin | 50.88% | 72.70% | 62.52% | 56.52% | 38.25% |
Operating Margin | -48.54% | -106.45% | -101.69% | -166.47% | -182.26% |
Profit Margin | -38272.62% | -3536.04% | -118.84% | -147.32% | -227.06% |
Free Cash Flow Margin | -66.65% | 1113.37% | -107.95% | -180.41% | -178.59% |
EBITDA | -2 | -3.66 | -5 | -6.72 | -6.1 |
EBITDA Margin | -39.57% | -62.93% | -85.33% | -147.45% | -166.73% |
D&A For EBITDA | 0.45 | 2.53 | 0.96 | 0.87 | 0.57 |
EBIT | -2.45 | -6.19 | -5.96 | -7.58 | -6.67 |
EBIT Margin | -48.54% | -106.45% | -101.69% | -166.47% | -182.26% |
Advertising Expenses | 0.02 | 0.04 | 0.11 | 0.07 | 0.04 |